Skip to content

Pharmacological Study of Cefazolin Antibioprophylaxis in Liver Transplantation

Pharmacological Study of Cefazolin Antibioprophylaxis in Liver Transplantation

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04280237
Acronym
ProCeTH
Enrollment
0
Registered
2020-02-21
Start date
2020-03-31
Completion date
2020-03-18
Last updated
2021-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Prophylaxis, Cephazolin Adverse Reaction, Liver Transplant Infection, Surgical Site Infection

Keywords

antibiotic prophylaxis, liver transplant, surgical site infection, Cefazolin

Brief summary

This study describes Cefazolin pharmacokinetics variation to target levels during liver transplantation.

Detailed description

Cefazolin is one of the many drugs used in antibiotic prophylaxis during liver transplantation. However there are no study describing its pharmacokinetics during liver transplantation. Due to the severe pharmacokinetics interactions caused by both prior hepatopathy and surgical techniques we suppose that Cefazolin blood levels are very different from those targeted for antibiotic prophylaxis. This study aim to describe pharmacokinetics of Cefazolin during liver transplantation in order to adapt antibiotic prophylaxis strategy in case of unadapted measured levels.

Interventions

OTHERBlood samples

Blood samples

Sponsors

University Hospital, Tours
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 * patient undergoing liver transplantation * receiving Cefazolin as perioperative antibiotic prophylaxis to prevent surgical site infections

Exclusion criteria

* pregnant women * legal protection or protected adults * ongoing antibiotic treatment before liver transplantation * patient inability to receive information or express opposition to the study. * patient refusing participation

Design outcomes

Primary

MeasureTime frameDescription
Cefazolin blood concentrationBaseline up to 10 hoursCefazolin blood concentration will be measured at the moment of surgical incision and every hour until end of surgery

Secondary

MeasureTime frameDescription
Assess correlations between Cefazolin blood concentration and CHILD-PUGH scorebaselinePatient's CHILD-PUGH score before transplantation
Assess correlations between Cefazolin blood concentration and MELD scorebaselinePatient's MELD score before transplantation
Assess correlations between Cefazolin blood concentration and Cirrhosis etiologybaselineCause of cirrhosis
Assess correlations between Cefazolin blood concentration and Transplantation indicationbaselineCause leading to transplantation
Assess correlations between Cefazolin blood concentration and Transjugular intrahepatic portosystemic shunt (TIPS)baselineMedical history of TIPS
Assess correlations between Cefazolin blood concentration and CreatininebaselineCreatinine levels will be measured before transplantation
Assess correlations between Cefazolin blood concentration and HemodialysisbaselinePatient needing hemodialysis before liver transplantation
Assess correlations between Cefazolin blood concentration and AlbuminbaselineAlbumin levels will be measured before transplantation
Assess correlations between Cefazolin blood concentration and Surgery durationEnd of surgeryTime of surgical incision and end of the surgery will be noted
Assess correlations between Cefazolin blood concentration and Portal vein clamping timeEnd of surgeryTime of portal vein clamping and declamping during realization of vascular anastomosis will be noted
Assess correlations between Cefazolin blood concentration and Blood lossEnd of surgeryBlood loss quantification will be done throughout surgery
Assess correlations between Cefazolin blood concentration and Urine outputEnd of surgeryVolume of urine output during surgery
Assess correlations between Cefazolin blood concentration and Red cell transfusion unitEnd of surgeryThe number of red cell units transfused during transplantation will be counted at the end of surgery
Assess correlations between Cefazolin blood concentration and Platelet transfusion unitEnd of surgeryThe number of platelet units transfused during transplantation will be counted at the end of surgery
Assess correlations between Cefazolin blood concentration and Plasma transfusion unitEnd of surgeryThe number of plasma units transfused during transplantation will be counted at the end of surgery
Assess correlations between Cefazolin blood concentration and Intraoperative blood salvageEnd of surgeryIntraoperative blood salvage transfusion volume during surgery
Assess correlations between Cefazolin blood concentration and Crystalloid infusionEnd of surgeryAssess correlations between Cefazolin blood concentration and Volume of crystalloid infusion during surgery
Assess correlations between Cefazolin blood concentration and Colloid infusionEnd of surgeryVolume of colloid infusion during surgery
Assess correlations between Cefazolin blood concentration and Basal cardiac indexBaselineCardiac index value at the beginning of surgery
Assess correlations between Cefazolin blood concentration and Minimal cardiac indexEnd of surgeryMinimal index value during surgery
Assess correlations between Cefazolin blood concentration and Surgical site infectionDay 28Number of patient with surgical site infection in the 28 days post-surgery
Assess correlations between Cefazolin blood concentration and AscitisBaselineVolume of ascitis drained at the beginning of surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026